Development and Initial Validation of a Caregiver-Report Measure
护理人员报告措施的制定和初步验证
基本信息
- 批准号:10448239
- 负责人:
- 金额:$ 7.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-10 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAdultAffectCaregiversCaringCharacteristicsChildChildhoodClinicalClinical Practice GuidelineCommon Data ElementCommunitiesContinuity of Patient CareDataData CollectionDevelopmentDevice or Instrument DevelopmentEffectivenessEnsureFutureGoalsGoldGuidelinesHealth InsuranceHealth ServicesHealth Services AccessibilityHealth TechnologyHeterogeneityImpaired cognitionImpairmentIndividualInjuryInpatientsInsurance CoverageInternationalInterviewLanguage TherapyLiteratureMeasuresMedicalMedical RecordsMethodsModelingNeuropsychologyOccupationalOutcomeOutcome MeasurePatient-Focused OutcomesPatientsPopulationPrivatizationPrognosisPsychometricsPsychosocial FactorRaceRecoveryRehabilitation therapyReportingResearchResearch MethodologyResearch PersonnelResearch PriorityReview LiteratureRiskSamplingSchoolsScientistSeriesServicesSeveritiesSocioeconomic StatusSpeechStandardizationStructureSurveysTimeTraumatic Brain InjuryTraumatic Brain Injury recoveryTreatment EfficacyValidationVocational rehabilitationWorld Healthbasebehavior influencebehavioral healthcognitive interviewefficacy testingexperiencefunctional statushealth care availabilityimprovedinfancyinnovationinsurance claimsmHealthmeetingsmultidisciplinaryneurobehavioralpediatric traumatic brain injurypredictive modelingpreventprognosticationprogramspsychosocialrehabilitation serviceservice utilizationtreatment optimizationtreatment response
项目摘要
ABSTRACT
Unexplained heterogeneity in outcomes following traumatic brain injury (TBI) precludes accurate
prognostication and is cited as a critical barrier that partially accounts for decades of failed trials of
neuroprotective therapies. To address this critical barrier, several international research consortia were
established to better understand factors influencing recovery from pediatric and adult TBI. These efforts are
strengthened by the adoption of common data elements (CDEs), the “gold standard” of psychometrically
validated measures of outcomes and their predictors. One factor that may account for unexplained
heterogeneity in outcomes is rehabilitation utilization; however, it is not well studied because no scientifically
rigorous, comprehensive, standardized, or validated measure of rehabilitation utilization currently exists. TBI
rehabilitation encompasses a wide range of multidisciplinary services spanning the care continuum from the
ICU to the community. Utilization of rehabilitation services following pediatric TBI is highly variable. Our long-
term goal is to examine whether variance in rehabilitation utilization accounts for some of the unexplained
heterogeneity in outcomes following pediatric TBI. If we can reduce heterogeneity in our models of TBI
recovery, we can provide more accurate prognostication and improve our ability to test the efficacy of
treatments. As a critical first step, we will develop, refine, and conduct initial validation of a caregiver-report
measure of rehabilitation utilization, the Rehabilitation Utilization Measure (RUM). We will combine qualitative
and quantitative methods to engage caregiver, clinician, and scientist stakeholders in measure development
and refinement and to conduct initial measure validation. This proposal addresses NCMRR research priorities:
(1) understanding real-world health service access; (2) developing objective measures that may predict
rehabilitation treatment response; and (3) identifying, preventing, and treating key secondary conditions,
including cognitive impairment. Successful completion will result in an innovative, rigorous, initially validated
and refined caregiver-report measure of rehabilitation utilization that can be further validated and adapted for
research and clinical use in children or adults from wide-ranging rehabilitation populations and considered for
inclusion as a CDE in future TBI studies. The PIs will use this R03 data in direct support of an R01 with aims
to: (1) develop an mHealth version of the RUM; (2) examine accuracy and added value of caregiver reporting
of rehabilitation utilization relative to insurance claims data; and (3) examine associations of rehabilitation
utilization as reported on the RUM with its environmental (e.g. rehabilitation availability) and patient
characteristic (e.g. TBI severity, functional status, psychosocial adversity,
healthcare access
) determinants,
and with neurobehavioral outcomes. The potential impact of this research is to increase our understanding of
heterogeneity in TBI outcomes, improve research methods for investigating TBI outcomes and treatment, and
optimize the care of individuals at greatest risk of neurobehavioral impairment following TBI.
摘要
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Brain-derived neurotrophic factor Val66Met and neuropsychological functioning after early childhood traumatic brain injury.
- DOI:10.1017/s1355617722000194
- 发表时间:2023-03
- 期刊:
- 影响因子:0
- 作者:Treble-Barna A;Wade SL;Pilipenko V;Martin LJ;Yeates KO;Taylor HG;Kurowski BG
- 通讯作者:Kurowski BG
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lauren Terhorst其他文献
Lauren Terhorst的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 7.95万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 7.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 7.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 7.95万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 7.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 7.95万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 7.95万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 7.95万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 7.95万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 7.95万 - 项目类别:
Standard Grant